Baraniuk et al. J. Appl. Physiol. (1992), 73(5), 1867-72, May 1992.* |
Lacroix et al. J. Allergy Clin. Immunol. (1996), 98(3), 611-616, Mar. 1996.* |
Lacroix et al. Br. J. Pharmacol. (1996), 118(8), 2074-2084, Aug. 1996.* |
McLean et al. J. Allergy Clin. Immunol. 59(2), 165-170, Feb. 1977.* |
Corren et al. Current Opinion in Pulmonary Medicine, (1999 Jan) 5 (1) 35-7, May 1992.* |
Grouzmann et al. J. Biol. Chem., 272(12), 7699-7706, Mar. 1997.* |
Baraniuk, et al., “Neuropeptide Y (NPY) in Human Nasal Mucosa,” Am. J. Respir. Cell. Mol. Biol. 3:165-173 (1990). |
Baraniuk, et al., “Neuropeptide Y is a Vasoconstrictor in Human Nasal Mucosa,” J. Applied Physiol. 73:1867-1872 (1992). |
Beck-Sickinger, et al., “Complete L-Alanine Scan of Neuropeptide Y Reveals Ligands Binding to Y1 and Y2 Receptors With Distinguished Conformations,” Eur. J. Biochem. 225:947-958 (1994). |
Dumy, et al., “A Convenient Synthesis of Cyclic Peptides as Regioselectively Addressable Functionalized Templates (RAFT),” Tetrahedron Letters 36:1255-1258 (1995). |
Ekblad, et al., “Neuropeptide Y Co-exists and Co-operates With Noradrenaline in Perivascular Nerve Fibers,” Regulatory Peptides 8:225-235 (1984). |
Ernest, et al., “Three Novel Mimics for the Construction of Sterically Constrained Protein Turn Models,” Tetrahedron Letters 31:4011-4014 (1990). |
Ernest, et al., “Cyclic Templates With Incorporated Turn-Inducing Mimics,” Helvetica Chimica Acta 76:1539-1563 (1993). |
Futaki, et al., “Preparation of Peptide Thioesters Using Fmoc-Solid-Phase Peptide Synthesis and Its Application to the Construction of a Template-Assembled Synthetic Protein (TASP),” Tetrahedron Letters 38:6237-6240 (1997). |
Grouzmann, et al., “A Specific Template-Assembled Peptidic Agonist for the Angiotensin II Receptor Subtype 2 (AT2) and Its Effect on Inferior Olivary Neurones,” Eur. J. Biochem. 234:44-49 (1995). |
Grouzmann, et al., “Characterization of a Selective Antagonist Neuropeptide Y at the Y2 Receptor,” J. Biol. Chem. 272:7699-7706 (1997). |
Grove, et al., “Template-Assembled Synthetic Proteins Designed to Adopt a Globular, Four-Helix Bundle Conformation Form Ionic Channels in Lipid Bilayers,” J. Am. Chem. Soc. 115:5919-5924 (1993). |
LaCroix, et al., “Intranasal Administration of Neuropeptide Y in Man: Systemic Absorption and Functional Effects,” Brit. J. Pharmacol. 118:2079-2084 (1996). |
LaCroix, et al., “Attenuation of Allergen-Evoked Nasal Responses by Local Pretreatment With Exogenous Neuropeptide Y in Atopic Patients,” J. Allergy Clin. Immunol. 98:611-616 (1996). |
LaCroix, et al., “Post-Exercise Nasal Vasoconstriction and Hyporeactivity: Possible Involvement of Neuropeptide Y,” Acta Otolaryngol (Stockh.) 117:000-000 (1997). |
Michel, “Receptors for Neuropeptide Y: Multiple Subtypes and Multiple Second Messengers,” Trends in Parmacol. Sci. 12:389-394 (1991). |
Minth, et al., “Cloning, Characterization, and DNA Sequence of a Human cDNA Encoding Neuropeptide Tyrosine,” Proc. Natl. Acad. Sci. USA 81:4577-4581 (1984). |
Mutter et al., “Artificial Folding Units of Assembly of Amphiphilic Secondary Structures on a Template,” Helvetica Chimica Acta 71:835-847 (1988). |
Mutter, “Nature's Rules and Chemist's Tools: A Way for Creating Novel Proteins,” Trends in Biochem. Sci. 13:260-265 (1988). |
Mutter, et al., “A Chemical Approach to Protein Design-Template-Assembled Synthetic Proteins (TASP),” Angewandte Chemie 28:535-676 (1989). |
Mutter, et al., “Template-Assembled Synthetic Proteins With Four-Helix-Bundle Topology. Total Chemical Synthesis and Conformational Studies,” J. Am. Chem. Soc. 114:1463-1470 (1992). |
Mutter, et al., “Non-Native Architectures in Protein Design and Mimicry,” CMLS, Cell. Mol. Life. Sci. 53:851-863 (1997). |
Nyanguile, et al., “Synthesis of Antiparallel 4α-Helix Bundle TASP by Chemoselective Ligation,” Letters in Peptide Sci. 1:9-16 (1994). |
Rist, et al., “Modified, Cyclic Dodecapeptide Analog of Neuropeptide Y is the Smallest Full Agonist at the Human Y2 Receptor,” FEBS Letters 394:169-173 (1996). |
Sahu, et al., “Neuropeptidergic Regulation of Feeding Behavior, Neuropeptide Y,” Trends in Endocrinology & Metabolism 4:217-224 (1993). |
Sila, et al., “Topological Templates as Tool in Molecular Recognition and Peptide Mimicry: Synthesis of a TASK Library,” J. Mol. Recog. 8:29-34 (1995). |
Stanley, et al., “Neuropeptide Y Injected in the Paraventricular Hypothalamus: A Powerful Stimulant of Feeding Behavior,” Proc. Natl. Acad. Sci. USA 82:3940-2943 (1985). |
Tuchscherer, et al., “Total Chemical Synthesis, Characterization, and Immunological Properties of an MHC Class I Model Using the TASP Concept for Protein de novo Design,” Protein Science 1:1377-1386 (1992). |
Tuchscherer, et al., “Designing Novel Proteins,” Chemistry & Industry 4:597-601 (1997). |
Wahlestedt, et al., “Neuropeptide Y-Related Peptides and Their Receptors-Are the Receptors Potential Therapeutic Drug Targets?, ” Ann. Rev. Pharmacol. Toxicol. 32:309-352 (1993). |
Walker, et al., “The Role of Neuropeptide Y in Cardiovascular Regulation,” Trends in Pharmacol. Sci. 12:111-115 (1991). |